SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-289288
Filing Date
2019-11-12
Accepted
2019-11-12 07:52:10
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d797581d10q.htm 10-Q 415268
2 EX-31.1 d797581dex311.htm EX-31.1 11011
3 EX-31.2 d797581dex312.htm EX-31.2 11004
4 EX-32.1 d797581dex321.htm EX-32.1 4836
5 EX-32.2 d797581dex322.htm EX-32.2 4830
  Complete submission text file 0001193125-19-289288.txt   2983138

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20190930.xml EX-101.INS 500692
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20190930.xsd EX-101.SCH 33677
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20190930_cal.xml EX-101.CAL 20204
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20190930_def.xml EX-101.DEF 232514
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20190930_lab.xml EX-101.LAB 281175
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20190930_pre.xml EX-101.PRE 267124
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 191206164
SIC: 2834 Pharmaceutical Preparations